abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

19 Dec 2011

Author:
B-HRD (Business and Human Rights Documentation Project)

In Focus: Big Pharma and Access to HIV/AIDS Drugs

See all tags
Millions in the developing world depend on affordable generic medicines. As multinational pharmaceutical companies pursue strategies to protect patents for key drugs in India and Brazil, access to essential medicines is frustrated and concerns regarding the rising cost of life-saving drugs intensify. [with sections on "Business Impacts on Human Rights"; "Demanding Justice"; and "Human Rights Defenders"]